Case Report | Open Access
Leptomeningeal Carcinomatosis Secondary to Gastroesophageal Adenocarcinoma: A Case Report and Literature Review of a Rare Occurrence
We present a 68-year-old male with leptomeningeal carcinomatosis (LC) from gastroesophageal junction carcinoma. Three months following epirubicin, cisplatin, 5-flurouracil (ECF) chemotherapy, the patient suffered from gait imbalance, headache, and dysarthria. CT and MRI imaging revealed LC throughout the brain and spine. The patient was prescribed dexamethasone and treated with a course of palliative radiation to the whole brain, 2000cGy/5. Additionally, the regions of symptomatic disease in the spine included the top of L4 vertebrae to the bottom of the S2 vertebrae which was treated with 2000cGy/5, and the top of the C5 vertebrae to the bottom of the T4 vetebrae received 800cGy/1. The radiation treatment did provide short-term symptom control; however, the patient eventually passed away from his illness. While LC remains a devastating complication of malignant disease, it has been rarely discussed in GI tumors, specifically GE junction adenocarcinomas. Therefore treatment options must be considered using first principles based on management of LC in more common disease sites. With early detection, and for patients with good performance status, palliative radiation utilizing hypofractionated regimens to sites of symptomatic involvement may improve quality of life for this group of unfortunate people.
- S. Taillibert, F. Laigle-Donadey, C. Chodkiewicz, M. Sanson, K. Hoang-Xuan, and J.-Y. Delattre, “Leptomeningeal metastases from solid malignancy: a review,” Journal of Neuro-Oncology, vol. 75, no. 1, pp. 85–99, 2005.
- H. G. Lee, B. Lee, S. M. Kim, B. J. Suh, and H. J. Yu, “A case of gastric adenocarcinoma presenting as meningeal carcinomatosis,” The Korean Journal of Internal Medicine, vol. 22, no. 4, pp. 304–307, 2007.
- H. Okumura, S. Natsugoe, N. Yokomakura et al., “A case of leptomeningeal carcinomatosis from esophageal basaloid carcinoma diagnosed by quantitative reverse transcription-polymerase chain reaction for carcinoembryonic antigen,” Journal of Gastroenterology, vol. 40, no. 1, pp. 87–93, 2005.
- Y. Lisenko, A. J. Kumar, J. Yao, J. Ajani, and L. Ho, “Leptomeningeal carcinomatosis originating from gastric cancer: report of eight cases and review of the literature,” American Journal of Clinical Oncology, vol. 26, no. 2, pp. 165–170, 2003.
- G. Y. Ku, G. Krol, and D. H. Ilson, “Successful treatment of leptomeningeal disease in colorectal cancer with a regimen of bevacizumab, temozolomide, and irinotecan,” Journal of Clinical Oncology, vol. 25, no. 13, pp. 14e–16, 2007.
- K. Goddeeris, C. Verslype, G. Wilms, and E. Van Cutsem, “Leptomeningeal carcinomatosis associated with oesophageal adenocarcinoma: two case reports and review of the literature,” Acta Gastro-Enterologica Belgica, vol. 69, no. 4, pp. 377–380, 2006.
- A. A. Abdo, S. Coderre, and R. J. Bridges, “Leptomeningeal carcinomatosis secondary to gastroesophageal adenocarcinoma: a case report and review of the literature,” Canadian Journal of Gastroenterology, vol. 16, no. 11, pp. 807–811, 2002.
- L. E. Abrey, M. C. Chamberlain, and H. H. Engelhar, Eds., Leptomeningeal Metastases, Cancer Treatment and Research, Edited by S. T. Rosen, Springer, Glenwood Springs, Colo, USA, 2005.
- G. Bonadonna, G. N. Hortobagyi, and A. M. Gianni, Eds., Textbook of Breast Cancer: A Clinical Guide to Therapy, Martin Dunitz/Taylor & Francis, London, UK, 2nd edition, 2001.
- J.-L. Lee, Y.-K. Kang, T.-W. Kim et al., “Leptomeningeal carcinomatosis in gastric cancer,” Journal of Neuro-Oncology, vol. 66, no. 1-2, pp. 167–174, 2004.
Copyright © 2009 Gunita Mitera et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.